Department of Critical Care, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, the Netherlands.
Department of Cardiology, Amsterdam University Medical Centers, Location Academic Medical Centers, Amsterdam, the Netherlands.
Transfusion. 2023 Oct;63(10):1809-1820. doi: 10.1111/trf.17505. Epub 2023 Sep 5.
Evidence-based recommendations for transfusion in patients with venoarterial extracorporeal membrane oxygenation (VA ECMO) are scarce. The current literature is limited to single-center studies with small sample sizes, therefore complicating generalizability. This study aims to create an overview of red blood cell (RBC) transfusion in VA ECMO patients.
This international mixed-method study combined a survey with a retrospective observational study in 16 centers. The survey inventoried local transfusion guidelines. Additionally, retrospective data of all adult patients with a VA ECMO run >24 h (January 2018 until July 2019) was collected of patient, ECMO, outcome, and daily transfusion parameters. All patients that received VA ECMO for primary cardiac support were included, including surgical (i.e., post-cardiotomy) and non-surgical (i.e., myocardial infarction) indications. The primary outcome was the number of RBC transfusions per day and in total. Univariable logistic regressions and a generalized linear mixed model (GLMM) were performed to assess factors associated with RBC transfusion.
Out of 419 patients, 374 (89%) received one or more RBC transfusions. During a median ECMO run of 5 days (1st-3rd quartile 3-8), patients received a median total of eight RBC units (1st-3rd quartile 3-17). A lower hemoglobin (Hb) prior to ECMO, longer ECMO-run duration, and hemorrhage were associated with RBC transfusion. After correcting for duration and hemorrhage using a GLMM, a different transfusion trend was found among the regimens. No unadjusted differences were found in overall survival between either transfusion status or the different regimens, which remained after adjustment for potential confounders.
RBC transfusion in patients on VA ECMO is very common. The sum of RBC transfusions increases rapidly after ECMO initiation, and is dependent on the Hb threshold applied. This study supports the rationale for prospective studies focusing on indications and thresholds for RBC transfusion.
目前缺乏关于脉动脉体外膜肺氧合(VA ECMO)患者输血的循证推荐意见。现有文献仅限于单中心研究且样本量较小,因此难以推广。本研究旨在概述 VA ECMO 患者的红细胞(RBC)输血情况。
本国际混合方法研究结合了一项调查和 16 个中心的回顾性观察研究。该调查列出了当地的输血指南。此外,还收集了所有 VA ECMO 运行时间超过 24 小时(2018 年 1 月至 2019 年 7 月)的成年患者的回顾性数据,包括患者、ECMO、结局和每日输血参数。所有接受 VA ECMO 治疗的患者均纳入原发性心脏支持,包括手术(即心脏手术后)和非手术(即心肌梗死)适应证。主要结局是每日和总红细胞输注量。采用单变量逻辑回归和广义线性混合模型(GLMM)评估与 RBC 输血相关的因素。
在 419 例患者中,有 374 例(89%)接受了一次或多次 RBC 输血。在中位 ECMO 运行时间为 5 天(1 四分位间距 3-8)期间,患者接受了中位总 8 单位 RBC(1 四分位间距 3-17)。ECMO 前血红蛋白(Hb)较低、ECMO 运行时间较长和出血与 RBC 输血相关。使用 GLMM 校正持续时间和出血后,不同的输血方案中发现了不同的输血趋势。在未调整输血状态或不同方案的情况下,总体生存率没有差异,在调整潜在混杂因素后仍然如此。
VA ECMO 患者的 RBC 输血非常常见。ECMO 启动后,RBC 输血总量迅速增加,且依赖于应用的 Hb 阈值。本研究支持了针对 RBC 输血适应证和阈值进行前瞻性研究的理由。